These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38215035)

  • 1. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
    Wang R; Xiao Y; Ma L; Wu Z; Xia H
    Gynecol Obstet Invest; 2022; 87(6):398-405. PubMed ID: 36273460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
    Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix.
    Shen T; Jiang YH; Zou YY; Qiu FF; Qiu XS; You KY
    Radiat Oncol; 2019 Nov; 14(1):203. PubMed ID: 31722727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
    Ishikawa M; Kasamatsu T; Tsuda H; Fukunaga M; Sakamoto A; Kaku T; Nakanishi T; Hasumi Y; Iwata T; Baba T; Nogawa T; Kudaka W; Kaneda H; Ono S; Saito F; Taniguchi Y; Okada S; Mizuno M; Onda T; Yaegashi N
    Gynecol Oncol; 2018 Jan; 148(1):139-146. PubMed ID: 29113721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
    Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
    Yuan L; Jiang H; Lu Y; Guo SW; Liu X
    Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
    Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study.
    Xie S; Song L; Yang F; Tang C; Yang S; He J; Pan X
    Medicine (Baltimore); 2017 Mar; 96(11):e6361. PubMed ID: 28296773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.
    Kim JH; Shim SH; Nam SH; Lee SW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT
    J Minim Invasive Gynecol; 2020; 27(7):1558-1565. PubMed ID: 32084588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
    An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 15. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
    Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
    Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
    Zhang Y; Ding J; Hua K
    J Int Med Res; 2022 Jan; 50(1):3000605211067397. PubMed ID: 34986672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of clinicopathological characteristics and comprehensive treatment models on the prognosis of small cell carcinoma of the cervix: A systematic review and meta-analysis.
    Zhang Q; Xiong Y; Ye J; Zhang L; Li L
    PLoS One; 2018; 13(4):e0192784. PubMed ID: 29641578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
    Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
    Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell carcinoma of the uterine cervix: a multi-institutional experience.
    Li J; Ouyang Y; Tao Y; Wang L; Li M; Gao L; Cao X
    Int J Gynecol Cancer; 2020 Feb; 30(2):174-180. PubMed ID: 31792086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
    Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.